On March 5, 2020, the Commissioner of the U.S. Food and Drug Administration (FDA) released a statement describing the agency’s continued evaluation of cannabidiol (CBD) products and signaling issuance of
Continue Reading FDA Commissioner Signals Enforcement Policy, Advancement of Research for CBD Products
